KOS PHARMACEUTICALS INC 4
4 · KOS PHARMACEUTICALS INC · Filed May 18, 2005
Insider Transaction Report
Form 4
MCGOVERN MARK E
Exec VP/Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock, $.01 Par Value
2005-05-16$19.88/sh+10,000$198,800→ 14,168 total - Sale
Common Stock, $.01 Par Value
2005-05-16$53.00/sh−10,000$530,000→ 4,168 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-05-16−10,000→ 0 totalExercise: $19.88Exp: 2010-10-16→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Includes 4,168 shares of Kos common stock acquired by reporting person in transactions exempt under Section 16 of the Exchange Act under the Kos 401(k) plan and the Employee Stock Purchase Plan.
- [F2]Part of an original grant of 35,000 options, exercisable in the following amounts on the following exercise dates: 8,750 on October 17, 2001 8,750 on October 17, 2002 8,750 on October 17, 2003 8,750 on October 17, 2004